ArticleDrug design, development and therapy2025
Quality by Design Formulation Approach for the Development of Orodispersible Tablets of Dexlansoprazole.
Arbab Tahir Ali et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it